The past couple of years have been quite eventful for life science and analytical instruments companies, characterized by major mergers and acquisitions, new product launches, partnerships, as well as other business developments. With growing government spending on pharmaceutical research and development (R&D) activities in emerging economies, technological advancements, elevated drug...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian